Literature DB >> 4005115

Oxprenolol absorption in man after single bolus dosing into two segments of the colon compared with that after oral dosing.

K H Antonin, P Bieck, M Scheurlen, M Jedrychowski, H Malchow.   

Abstract

The systemic availability of oxprenolol after colonic and oral administration has been compared in a crossover study involving six healthy male volunteers. Drug administration into two regions of the colon (caecum and left flexure) was achieved by means of a colonoscopic technique. There were no obvious differences in plasma concentrations after drug administration to the caecum and left flexure, although in one subject it was necessary to repeat colonic administration because of unexpectedly high plasma drug levels on the first occasion. The possible reasons for this abnormal response are discussed. The mean systemic availability of oxprenolol was 82% after colonic compared with oral dosing, although marked differences were observed in individual plasma levels following drug administration by the two routes. The results of this study support the concept of extending the duration of oxprenolol release from a rate-controlled dosage form to permit once-daily administration with this short elimination half-life drug.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4005115      PMCID: PMC1463770          DOI: 10.1111/j.1365-2125.1985.tb02754.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  17 in total

1.  Simplified method for the determination of oxprenolol and other beta-receptor-blocking agents in biological fluids by gas-liquid chromatography.

Authors:  P H Degen; W Riess
Journal:  J Chromatogr       Date:  1976-06-09

2.  Pharmacokinetics of oxprenolol in normal subjects.

Authors:  W D Mason; N Winer
Journal:  Clin Pharmacol Ther       Date:  1976-10       Impact factor: 6.875

3.  Transit through the gut measured by analysis of a single stool.

Authors:  J H Cummings; H S Wiggins
Journal:  Gut       Date:  1976-03       Impact factor: 23.059

4.  Ammonia absorption from the human colon. The role of nonionic diffusion.

Authors:  D O Castell; E W Moore
Journal:  Gastroenterology       Date:  1971-01       Impact factor: 22.682

Review 5.  Assessment of the drug metabolism capacity of the liver.

Authors:  B K Park
Journal:  Br J Clin Pharmacol       Date:  1982-11       Impact factor: 4.335

6.  Current endoscopic practice in the United Kingdom.

Authors:  D G Colin-Jones; R Cockel; K F Schiller
Journal:  Clin Gastroenterol       Date:  1978-09

7.  Rectal bioavailability of lidocaine in man: partial avoidance of "first-pass" metabolism.

Authors:  A G de Boer; D D Breimer; H Mattie; J Pronk; J M Gubbens-Stibbe
Journal:  Clin Pharmacol Ther       Date:  1979-12       Impact factor: 6.875

8.  Absorption of digoxin in man after oral and intrasigmoid administration studied by portal vein catheterization.

Authors:  K E Andersson; L Nyberg; H Dencker; J Göthlin
Journal:  Eur J Clin Pharmacol       Date:  1975-10-10       Impact factor: 2.953

9.  Investigation of small bowel transit time in man utilizing pulmonary hydrogen (H2) measurements.

Authors:  J H Bond; M D Levitt; R Prentiss
Journal:  J Lab Clin Med       Date:  1975-04

10.  Polymorphic hydroxylation of Debrisoquine in man.

Authors:  A Mahgoub; J R Idle; L G Dring; R Lancaster; R L Smith
Journal:  Lancet       Date:  1977-09-17       Impact factor: 79.321

View more
  7 in total

1.  Regional differences in quinine absorption from the undisturbed human colon assessed using a timed release delivery system.

Authors:  J M Hebden; C G Wilson; R C Spiller; P J Gilchrist; E Blackshaw; M E Frier; A C Perkins
Journal:  Pharm Res       Date:  1999-07       Impact factor: 4.200

2.  Relationship between the rate of appearance of oxprenolol in the systemic circulation and the location of an oxprenolol Oros 16/260 drug delivery system within the gastrointestinal tract as determined by scintigraphy.

Authors:  S S Davis; N Washington; G D Parr; A H Short; V A John; P Lloyd; S M Walker
Journal:  Br J Clin Pharmacol       Date:  1988-10       Impact factor: 4.335

3.  Jejunal and ileal absorption of oxprenolol in man: influence of nutrients and digestive secretions on jejunal absorption and systemic availability.

Authors:  J Godbillon; N Vidon; R Palma; A Pfeiffer; C Franchisseur; M Bovet; G Gosset; J J Bernier; J Hirtz
Journal:  Br J Clin Pharmacol       Date:  1987-09       Impact factor: 4.335

4.  In vitro and in vivo deconvolution assessment of drug release kinetics from oxprenolol Oros preparations.

Authors:  F Langenbucher; J Mysicka
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

5.  Zero-order release formulation of oxprenolol hydrochloride with swelling and erosion control.

Authors:  K P Devi; K V Rao; S Baveja; M Fathi; M Roth
Journal:  Pharm Res       Date:  1989-04       Impact factor: 4.200

Review 6.  Effects of surgery on the pharmacokinetic parameters of drugs.

Authors:  J M Kennedy; A M Riji
Journal:  Clin Pharmacokinet       Date:  1998-10       Impact factor: 6.447

7.  Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup.

Authors:  Josée Bouchard; Greene Shepherd; Robert S Hoffman; Sophie Gosselin; Darren M Roberts; Yi Li; Thomas D Nolin; Valéry Lavergne; Marc Ghannoum
Journal:  Crit Care       Date:  2021-06-10       Impact factor: 9.097

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.